| Nazwa produktu | Bunanselin |
|---|---|
| Numer CAS | 132810-10-7 |
| Wzór cząsteczkowy | C₁₉H₂₁N₃O₄S |
| Masa cząsteczkowa | 387.45 |
| Wygląd | Biały lub prawie biały krystaliczny proszek |
| Oznaczenie (HPLC) | ≥98% |
| Strata przy suszeniu | ≤0,51 TP3T |
| Popiół po spaleniu | ≤0,11 TP3T |
| Metale ciężkie | ≤10 ppm |
| Temperatura topnienia | 178-182°C |
Potrzebujesz pomocy? Skontaktuj się z naszym zespołem

Bunanselin, 132810-10-7, 3-(3,4-dimethoxyphenyl)-N-methyl-2-oxo-2H-chromene-7-carboxamide
Bunanselin is making its mark in the pharmaceutical intermediate space, and not just for its long name. It’s a coumarin derivative that’s drawing attention for its potential in medicinal chemistry — specifically as a building block for compounds targeting inflammatory and oxidative stress pathways. That’s the kind of versatility that gets formulators excited.
We supply Bunanselin as a high-purity crystalline powder, consistent from batch to batch. Whether you’re running a small-scale R&D trial or scaling up for commercial production, we’ve got the capacity to match.